efavirenz has been researched along with Allergy, Drug in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 14 (63.64) | 29.6817 |
| 2010's | 7 (31.82) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bayonne Kombo, ES; Gathse, A | 1 |
| Dodderi, SK; Govindaraj, M; Pavithra, HB; Premalatha, R; Rewari, BB; Sanjeeva, GN; Shivananda, S; Sukanya, V | 1 |
| Bertelli, A; D'Erme, AM; Gola, M; Severino, M; Tchoimou, T; Testi, S; Tiradritti, L; Zuccati, G | 1 |
| Antônio Gomes de Arruda, É; de Oliveira Rodrigues, R; Farias Ribeiro, I; Fernandes Ribeiro da Silva, S; Germano de Carvalho, P; Helena Barem Rabenhorst, S; Luri Sasahara, G; Mabel Ferreira Vasconcelos, L; Tiemi Nagao-Dias, A | 1 |
| Roca, B | 1 |
| Curry, E; Thomas, M; Yehia, M | 1 |
| Kiertiburanakul, S; Malathum, K; Sathapatayavongs, B; Sungkanuparph, S; Watcharananan, S | 1 |
| Bravo, I; Carosi, G; Clotet, B; del Arco, A; Echeverría, P; Gálvez, J; Gómez, JL; López, JC; López-Blazquez, R; Mariño, A; Moreno, A; Negredo, E; Ocampo, A; Pedrol, E; Pérez-Alvarez, N; Portilla, J; Prieto, A; Rubio, R; Viladés, C | 1 |
| Domingo, P; Gutierrez, Mdel M; Mateo, MG; Vidal, F | 1 |
| Farasatinasab, M; Hajiabdolbaghi, M; Khalili, H | 1 |
| Bossi, P; Bricaire, F; Caumes, E; Katlama, C | 1 |
| Delgado, J; Shulman, N | 1 |
| Angel-Moreno-Maroto, A; Hernández-Cabrera, M; Pérez-Arellano, JL; Suárez-Castellano, L | 1 |
| Brothers, CH; Castillo, SA; Hernandez, JE | 1 |
| Mira, JA; Pineda, JA; Rivero, A | 1 |
| Galli, M; Gervasoni, C; Grinelli, E; Ortu, M; Rusconi, S; Vigano, O | 1 |
| Leung, JM; O'Brien, JG; Winslow, DL; Wong, HK | 1 |
| Bossi, P; Bricaire, F; Caumes, E; Colin, D | 1 |
| Consiglio, E; Ferrer, E; Gudiol, F; Podzamczer, D | 1 |
| Bartnof, HS | 1 |
| Behrens, GM; Schmidt, RE; Stoll, M | 1 |
| Knowles, SR; Kuriakose, B; Phillips, EJ | 1 |
6 review(s) available for efavirenz and Allergy, Drug
| Article | Year |
|---|---|
Pharmacogenomics of antiretrovirals.
Topics: Alkynes; Anti-Retroviral Agents; Aryl Hydrocarbon Hydroxylases; Atazanavir Sulfate; Benzoxazines; Central Nervous System Diseases; Cyclopropanes; Cytochrome P-450 CYP2B6; Dideoxynucleosides; Drug Hypersensitivity; Drug Resistance, Viral; Dyslipidemias; Genetic Predisposition to Disease; Genetic Testing; Glucuronosyltransferase; HLA Antigens; Humans; Hyperbilirubinemia; Nevirapine; Oligopeptides; Oxidoreductases, N-Demethylating; Patents as Topic; Patient Selection; Pharmacogenetics; Pyridines; Ritonavir | 2008 |
The toxicogenetics of antiretroviral therapy: the evil inside.
Topics: Alkynes; Anti-Retroviral Agents; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Drug Hypersensitivity; Genetic Variation; Humans; Nevirapine; Oligopeptides; Polymorphism, Single Nucleotide; Pyridines; Reverse Transcriptase Inhibitors; Toxicogenetics | 2011 |
[Antiretroviral-induced toxiderma in HIV-infected patients].
Topics: Alkynes; Anti-HIV Agents; Anti-Inflammatory Agents; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Drug Hypersensitivity; Exanthema; Histamine H1 Antagonists; HIV Infections; HIV Protease Inhibitors; Humans; Nevirapine; Oxazines; Reverse Transcriptase Inhibitors; Risk Factors; Steroids; Stevens-Johnson Syndrome | 2003 |
NNRTI hypersusceptibility.
Topics: Alkynes; Benzoxazines; Clinical Trials as Topic; Cyclopropanes; Drug Hypersensitivity; Drug Resistance, Viral; HIV Infections; Humans; Oxazines; Reverse Transcriptase Inhibitors; Viral Load | 2005 |
Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors.
Topics: Alanine Transaminase; Alkynes; Anti-HIV Agents; Aspartate Aminotransferases; Benzoxazines; Chemical and Drug Induced Liver Injury; Cyclopropanes; Drug Hypersensitivity; Humans; Liver; Nevirapine; Reverse Transcriptase Inhibitors; Risk Factors | 2007 |
Efavirenz-induced hypersensitivity reaction manifesting in rash and hepatitis in a Latino male.
Topics: Adult; Alkynes; Benzoxazines; Cyclopropanes; Drug Hypersensitivity; Exanthema; Hepatitis; Hispanic or Latino; Humans; Male | 2008 |
1 trial(s) available for efavirenz and Allergy, Drug
| Article | Year |
|---|---|
Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with abacavir/lamivudine (Kivexa), in antiretroviral-naïve patients: a 48-week, multicentre, randomized study (Lake Study).
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Dideoxynucleosides; Drug Combinations; Drug Hypersensitivity; Female; HIV Infections; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Pyrimidinones; Ritonavir; RNA, Viral; Treatment Outcome; Viral Load; Withholding Treatment | 2010 |
15 other study(ies) available for efavirenz and Allergy, Drug
| Article | Year |
|---|---|
[Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV].
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Asthenia; Benzoxazines; Cyclopropanes; Deoxycytidine; Dideoxynucleosides; Drug Eruptions; Drug Hypersensitivity; Drug Substitution; Emtricitabine; Female; Fever; HIV Infections; Humans; Lamivudine; Nevirapine; Organophosphonates; Reverse Transcriptase Inhibitors; Syndrome; Tenofovir | 2013 |
Nevirapine-related adverse events among children switched from efavirenz to nevirapine as compared to children who were started on nevirapine-based antiretroviral therapy directly.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Child; Child, Preschool; Cyclopropanes; Drug Administration Schedule; Drug Hypersensitivity; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Incidence; India; Male; Nevirapine; Retrospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome | 2015 |
Two cases of successful efavirenz desensitization in patients with several anti-HIV drugs hypersensitivities.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Desensitization, Immunologic; Drug Eruptions; Drug Hypersensitivity; Female; HIV Infections; Humans; Male; Middle Aged; Reverse Transcriptase Inhibitors | 2015 |
Association of IL10, IL4, IFNG, and CTLA4 Gene Polymorphisms with Efavirenz Hypersensitivity Reaction in Patients Infected with Human Immunodeficiency Virus.
Topics: Adult; Aged; Alkynes; Anti-HIV Agents; Benzoxazines; Case-Control Studies; CTLA-4 Antigen; Cyclopropanes; Drug Hypersensitivity; Female; Genetic Predisposition to Disease; HIV Infections; Humans; Immunologic Factors; Interferon-gamma; Interleukin-10; Interleukin-4; Male; Middle Aged; Polymorphism, Single Nucleotide; Young Adult | 2017 |
Renal impairment and hypersensitivity reaction due to efavirenz.
Topics: Acute Kidney Injury; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Hypersensitivity; Humans; Male; Middle Aged | 2008 |
Predicting factors for unsuccessful switching from nevirapine to efavirenz in HIV-infected patients who developed nevirapine-associated skin rash.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Chi-Square Distribution; Cohort Studies; Cyclopropanes; Drug Hypersensitivity; Exanthema; Female; HIV Infections; Humans; Logistic Models; Male; Nevirapine; Retrospective Studies; Risk Factors; Statistics, Nonparametric; Viral Load | 2009 |
Efavirenz severe hypersensitivity reaction: case report and rapid desensitization protocol development.
Topics: Alkynes; Anti-Retroviral Agents; Benzoxazines; Clinical Protocols; Cyclopropanes; Drug Administration Schedule; Drug Hypersensitivity; Female; Humans; Middle Aged | 2012 |
Severe efavirenz-induced hypersensitivity syndrome (not-DRESS) with acute renal failure.
Topics: Acute Kidney Injury; Adenine; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Hypersensitivity; Ghana; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Male; Mycobacterium tuberculosis; Organophosphonates; Reverse Transcriptase Inhibitors; Ritonavir; Tenofovir; Tuberculosis | 2006 |
Long-term safety and tolerability of the lamivudine/abacavir combination as components of highly active antiretroviral therapy.
Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Controlled Clinical Trials as Topic; Cyclopropanes; Dideoxynucleosides; Drug Hypersensitivity; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Incidence; Lamivudine; Male; Oxazines; Prospective Studies; Time Factors; Treatment Outcome; Zidovudine | 2006 |
Abacavir hypersensitivity reaction after switching from the twice-daily to the once-daily formulation.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Dideoxynucleosides; Drug Administration Schedule; Drug Hypersensitivity; HIV Infections; Humans; Lamivudine; Male; Oxazines; RNA, Viral | 2007 |
Hypersensitivity syndrome associated with efavirenz therapy.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Hypersensitivity; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Oxazines; Reverse Transcriptase Inhibitors; Syndrome | 2000 |
Efavirenz associated with corticosteroids in patients with previous severe hypersensitivity reaction due to nevirapine.
Topics: Adrenal Cortex Hormones; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Nevirapine; Oxazines; Reverse Transcriptase Inhibitors | 2000 |
Selected highlights from the 5th Conference on Retroviruses and Opportunistic Infections.
Topics: AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antiviral Agents; Benzoxazines; Carbamates; Chicago; Clinical Trials as Topic; Congresses as Topic; Cyclopropanes; Dideoxynucleosides; Drug Hypersensitivity; Drug Interactions; Drug Therapy, Combination; Drugs, Investigational; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Hydroxyurea; Oxazines; Reverse Transcriptase Inhibitors; Sulfonamides | 1998 |
Pulmonary hypersensitivity reaction induced by efavirenz.
Topics: Adult; Alkynes; Alveolitis, Extrinsic Allergic; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Diagnosis, Differential; Drug Hypersensitivity; Humans; Male; Oxazines | 2001 |
Efavirenz-induced skin eruption and successful desensitization.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Desensitization, Immunologic; Drug Hypersensitivity; Exanthema; HIV Seropositivity; Humans; Male; Oxazines | 2002 |